These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1126477)

  • 1. [Modeling dystrophic myocardial lesions in dogs].
    Sagach VF
    Fiziol Zh; 1975; 21(2):201-6. PubMed ID: 1126477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modeling of myocardial lesions of varying degrees of manifestation].
    Reznikov KM; Leonov AN; Kitaeva RI; Bykov EG; Provotorova PP
    Biull Eksp Biol Med; 1985 May; 99(5):532-4. PubMed ID: 4005403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of repeated myocardial necrosis in animals with an ischemic infarct following exposure to an antigen from necrotic cardiac muscle].
    Fatenkov VN; Pechenina NV
    Patol Fiziol Eksp Ter; 1978; (4):6-9. PubMed ID: 704164
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic properties of the damaged heart muscle.
    Szabó S; Maros T; Lukács E; Ionescu M; Muntyán G
    Z Immunitatsforsch Allerg Klin Immunol; 1969 May; 137(5):492-500. PubMed ID: 4239402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune damage to the heart and blood vessels].
    Moĭbenko AA; Butenko GM
    Fiziol Zh (1978); 1981; 27(5):587-94. PubMed ID: 7297706
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of gross myocardial infarction in the canine heart.
    Ginks W; Ross J; Sybers HD
    Arch Pathol; 1974 Jun; 97(6):380-4. PubMed ID: 4825101
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in catecholamine concentration and myocardial contractility in focal cytotoxic lesions of the heart].
    Buriakov IE
    Fiziol Zh (1978); 1981; 27(6):780-5. PubMed ID: 7319074
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of the antihistaminic preparation fencarol on cardio- and hemodynamics and the energy processes in the myocardium in an infarct-like immune lesion of the heart].
    Moĭbenko AA; Frantsuzova SB; Sagach VF; Korkach VI; Sirotina MF
    Farmakol Toksikol; 1982; 45(6):28-32. PubMed ID: 6129997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiodynamics and myocardial contractility in immune heart injuries].
    Moĭbenko AA; Sagach VF
    Fiziol Zh; 1977; 23(2):182-90. PubMed ID: 863009
    [No Abstract]   [Full Text] [Related]  

  • 10. [Model of reinfarction of the myocardium in animals and characteristics of electrocardiographic changes].
    Eĭdinov IaB
    Vrach Delo; 1967; 9():36-9. PubMed ID: 5621776
    [No Abstract]   [Full Text] [Related]  

  • 11. [Functional and morphological research on the protective action of Neoton in immune heart damage].
    Moĭbenko AA; Marchenko GI; Popovich LF
    Fiziol Zh (1978); 1987; 33(5):54-63. PubMed ID: 3691871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modeling and experimental therapy of myocardial infarct in dogs].
    Maksimovich IaB; Aksel'rod LB; Legeda EA; Gaĭdenko AI; Lukashenko AA
    Fiziol Zh; 1978; 24(3):331-7. PubMed ID: 658492
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of cytosolic and mitochondrial aspartate aminotransferase in normal, ischemic, and necrotic myocardium. An immunohistochemical study.
    Siegel RJ; Edwalds G; Rej R; Fishbein MC
    Lab Invest; 1984 Dec; 51(6):648-54. PubMed ID: 6389975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct].
    Syroïd DV; Sokrut VM; Shvyrenko IR
    Fiziol Zh (1994); 1999; 45(6):26-30. PubMed ID: 10687078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Animal experimental immunohistological studies of the postmyocardial infarct syndrome].
    Roschlau G; Schuh D
    Acta Biol Med Ger; 1967; 19(2):339-42. PubMed ID: 4873543
    [No Abstract]   [Full Text] [Related]  

  • 16. [The efficacy of glucosamine in treating complicated hyperreactive experimental myocardial infarct].
    Sokrut VN; Zupanets IA; Iabluchanskiĭ NI; Drogovoz SM
    Farmakol Toksikol; 1991; 54(2):31-3. PubMed ID: 1653152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modeling a macrofocal myocardial infarct].
    Dmitrieva EM; Leonov AN; Reznikov KM; Trukhacheva LI; Taratinova TI
    Patol Fiziol Eksp Ter; 1983; (6):72-4. PubMed ID: 6664705
    [No Abstract]   [Full Text] [Related]  

  • 18. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of beta-adrenoreceptor blockade to increase the information value of indices of contractility during evaluation of the functional state of the myocardium].
    Kaz'min SG; Korkushko OV; Sagach VF; Shablovskaia OV; Moroz GZ
    Fiziol Zh (1978); 1986; 32(1):72-5. PubMed ID: 3956786
    [No Abstract]   [Full Text] [Related]  

  • 20. Rat model for acute myocardial infarction: application to technetium-labeled glucoheptonate, tetracycline, and polyphosphate.
    Adler N; Camin LL; Shulkin P
    J Nucl Med; 1976 Mar; 17(3):203-7. PubMed ID: 1249630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.